Methods and materials for the treatment of prostatic carcinoma
AssigneeZonagen, Inc.
InventorsChristopher Allen Seid, Gurpreet Singh
Life of this patent
Estimating the term…
Abstract
The present invention related generally to materials and methods for reduction and/or alleviation of prostatic and prostatic-related (metatastic) carcinoma via the administration of disclosed compositions, immunotherapeutic agents, or antibodies.
Claims4
A method of inhibiting the growth or alleviating prostatic carcinoma or metastatic caricnoma of prostatic orgigin, the method comprising the administration of a composition comprising prostate-specific antigen and a chitosan-metal chelate selected from the group consisting of chitosan-zinc chelates, chitosan-copper chelates, chitosan-iron chelates, and chitosan-nickel chelates.
Dependencies are inferred from the claim text.